US FDA’s Cell/Gene Therapy Office Looks To Improve Clarity Of Advice Through Written Responses

 
• By Sue Sutter
Inconsistency
FDA's Office of Tissues and Advanced Therapies is trying to improve the consistency and clarity of its advice to sponsors. • Source: Shutterstock

More from Cell & Gene Therapies

More from Advanced Technologies